OBJECTIVES: Any aortic valve (AoV) operation in children (repair, Ross or mechanical replacement) is a palliation and reinterventions are frequent. AoV repair is a temporary solution primarily aimed at allowing the patient to grow to an age when more definitive solutions are available. We retrospectively analysed AoV repair effectiveness across the whole age spectrum of children, excluding neonates and AoV disease secondary to congenital heart disease. From 2003From to 2015 consecutive patients were included. The mean age was 9.2 ± 6.9 years (22% <1 year); 86 (45%) had a preceding balloon valvuloplasty. The indications for the procedure were stenotic (n = 123; 64%), regurgitant (n = 63; 33%) or combined (n = 7; 4%) disease. The procedures performed were commissurotomy shaving (n = 74; 38%), leaflet replacement (n = 78; 40%), leaflet extension (n = 21; 11%) and neocommissure creation (n = 21; 11%). Post-repair geometry was tricuspid in 137 (71%) patients.
INTRODUCTION
During the 1980s and 1990s, the development of aortic valve (AoV) repair in children was veiled by the pre-eminence of competing techniques. In the 1980s, the technique of aortic balloon dilatation developed rapidly such that today it is the primary treatment modality used in most centres worldwide. During the 1990s, following experiences with adults, the Ross procedure was popularized in the paediatric field. Given the ideal features of the autograft substitute for children (absence of anticoagulation, no age limitation, and, among all, growth potential), this procedure, without difficulty, became the procedure of choice in children. This event allowed little room for the development of AoV repair techniques, which were limited to open valvulotomy in a few centres with a surgically oriented policy. Most children were managed first with balloon dilatation, leading to a Ross procedure; this approach was preferred to the uncertainty of the complex repair of a torn AoV. Two events over the last decade promoted a renewed interest in AoV repair in children: (i) the development and favourable results of AoV repair in adults (pioneered by El Khoury [1] and Sch€ affers [2] ), and by the demonstration of the reliability and superiority of repair in the mitral domain and (ii) emergence of Ross paediatric patients in their second postoperative decade, showing up to 40% autograft failure at 15 years [3, 4] .
For these reasons, since 2000, few centres have developed a repair-oriented policy for AoV disease in children. Among them, the Melbourne centre has developed world-renowned expertise [5] . However, long-term data are scarce because of the newness of the technique and the paucity of paediatric cohorts. Furthermore, prognostic factors are dramatically lacking to refine strategy in such a moving target as children. Thus, the place of repair in the armamentarium of techniques to manage AoV disease in children is still being debated [6] .
During the past decade, triggered by the large number of patients referred for surgical treatment after balloon dilatation and by the locally generated good results of AoV repair in infancy [7] , our centre has adopted a deliberate repair-oriented policy in patients with congenital AoV disease. We sought to investigate the long-term outcomes (survival and freedom from reoperation and replacement) of this policy in our non-neonatal group of patients and to determine the risk factors associated with such outcomes, specifically looking across age groups.
MATERIALS AND METHODS

Patient population
Institutional review board approval was obtained to conduct this retrospective follow-up study, and individual consent was waived. All patients who underwent primary (no previous repair) AoV repair from 2003 onwards were identified from our institutional database. The neonatal group was analysed separately. To focus on a homogeneous group of patients presenting with similar diseases, only patients with 'primary' disease of the AoV were included. Patients with valvar lesions secondary to subaortic stenosis, ventricular septal defect-related [preoperative (Laubry-Pezzi syndrome) or postoperative] AoV disease, Marfan syndrome, a common arterial trunk or a transposed aorta (transposition of the great arteries, Taussig-Bing anomaly, congenitally corrected transposition) were excluded.
Surgical technique
All procedures were performed by 2 experienced local surgeons. A standard cardiopulmonary bypass procedure was used (bicaval cannulation, antegrade intermittent cold crystalloid cardioplegia, mild hypothermia). An autologous pericardial patch was prepared (glutaraldehyde 0.3175%, 20 min). After transverse aortotomy, a systematic inspection (commissure development, leaflet anatomy and mobility) identified the dysfunction mechanism. A 3-step strategy was then applied, with the final objective being to restore valve mobility, with functional competent geometry, independently of the anatomy.
The first step consisted of leaflet remodelling, mainly to increase mobility through extensive debridement. Any obstructive myxomatous and fibrous nodules on the leaflets or at the ventriculo-arterial junction were removed. This procedure also implied careful thinning/shaving of the leaflets. Any thick raphe restricting leaflet motion was thinned down. Our surgical protocol was described previously [7] .
The second step consisted of suspending apparatus rehabilitation, mainly to restore a functional geometry (sufficient opening and competent coaptation). This step implied freeing procedures, with commissurotomy to free the commissural edge of the leaflet from the aortic wall. In the case of leaflet prolapse, restricting procedures were performed: commissural (Trusler) or free-edge plication, free-edge resuspension [with Gore-Tex sutures (W.L. Gore & Associates, Inc, Flagstaff, AZ, USA)], free edge triangular resection, subcommissural annuloplasty (Cosgrove) and commissure resuspension. Finally, when the geometry of the aortic root complex was unsatisfactory, a non-coronary sinus reduction or augmentation was performed.
Valve function was then tested: The effective orifice area was measured with a Hegar sizer (weight-normalized values) and coaptation was assessed.
The third step consisted of leaflet augmentation, performed in the case of persisting, unsatisfactory valvular function or, primarily, when the tissue (natively or torn leaflet secondary to balloon dilatation) was insufficient to reach the reconstruction. The reconstruction comprised leaflet replacement, free-edge extension or neocommissure creation. During the primary surgical procedure, all patches were treated as autologous pericardium. At this step, the surgeon always tried to maximize use of native tissue and reduce the use of foreign material to allow for potential growth. When one cusp had to be replaced because of hypoplasia, this leaflet was split into 2 parts (Video 1) and used to rebuild both commissures next to the new leaflet. For leaflet replacement, the patch was sized to obtain adequate coaptation without excessive redundant tissue. The free edge was oversized to accommodate root growth, but without oversizing the height to avoid coronary impingement. Creation of a neocommissure (Video 2) comprised resection of a raphe and creation of a new commissure using a triangular patch.
Routine transoesophageal echocardiography was used to assess the repair and to guide the revision if necessary. Revision was required in the case of a peak gradient >30 mmHg and/or greater than mild regurgitation. non-to-right commissure is underdeveloped. The underdeveloped right coronary leaflet is split: The thin part adjacent to the non-coronary leaflet is used for the right/non commissure autologous reconstruction; the other fibrotic-nodular part is removed. A new leaflet free edge is estimated (from commissure to commissure). A fixed autologous pericardial substitute leaflet is sutured to the annulus and, at the end, sutured with the remnant of the right coronary leaflet to reconstruct a full right/non commissure. Leaflet and commissure heights are adjusted similar to those of other segments. Post-repair echocardiography is performed.
During follow-up, reoperation was indicated for repeatedly measured peak gradient >60 mmHg, regurgitation greater than mild, and/or an left ventricular (LV) end-diastolic diameter zscore > _3.
Statistical analysis
End points were valve reoperation, replacement and mortality. Statistical analyses were performed using the R version 3.1.1 software (R-Foundation for Statistical Computing, www.r-project. org). Data are expressed as median and range or mean ± standard deviation. Comparison was achieved with the Fisher's exact test and the Student t-test. Freedom from an event was analysed using the Kaplan-Meier estimates with 95% confidence intervals (CI). Univariate analysis of time-related events was achieved using the log-rank test and the Cox model. Variables with P <0.20 or that were clinically relevant were included in the multivariate Cox model.
RESULTS
Patients
Between January 2003 and January 2016, we performed 354 consecutive AoV repairs. Of those, 205 patients met the inclusion criteria; 193 with available follow-up data were included.
The median age was 9.79 years (range, 0.1-28.7); 43 patients were younger than 1 year (22%); 54 were between 1 and 10 years (28%) and 96 were older than 10 years (50%). All were outpatients in New York Heart Association Class I-II. The aetiology of the valve disease was congenital in all patients. Valve dysfunction was stenotic in 123 patients (64%), regurgitant in 63 (33%) and combined in 7 (4%). Endocardial fibroelastosis was present in 13 patients (7%). Previous balloon dilatation was performed in 86 (45%) patients, with 62 (32%) cases performed before 6 months of age. Additional previous procedures included coarctation repair (n = 26), ventricular septal defect closure (n = 11), relief from LV outflow tract obstruction (n = 6) and aortic arch repair (n = 5).
At operation, valve morphology was unicuspid in 32 patients (17%), bicuspid in 108 (56%) and tricuspid in 53 (27%). A postrepair tricuspid arrangement was reached in 137 patients. Repair techniques and additional procedures [70 patients (36%)] are listed in Table 1 .
Mortality
The mean follow-up time was 5.1 ± 3.0 years.
The probabilities of survival at 1 and 10 years were, respectively, 99% (95% CI, 98.5-99.99%) and 97.1% (95% CI, 93.5-99.99%).
There was 1 early death (0.5%) after repair early in our experience (2004). An 18-year-old patient with a stenotic and regurgitant bicuspid valve was treated with tricuspidization (neocommissure creation). The patient could not be weaned from cardiopulmonary bypass, and extracorporeal membrane oxygenation was instituted. He died of multiorgan failure 4 days postoperatively. Ventricular failure was attributed to myocardial protection failure.
There were 2 late deaths (1%) after replacement. A 10-year-old girl who had neonatal balloon dilatation and AoV repair at 7 years of age (leaflet replacement) underwent the Ross procedure at 10 years of age, with normal LV function and pulmonary pressure. One month later, extracorporeal membrane oxygenation support was instituted for acute pulmonary hypertension (acute respiratory distress syndrome) and secondary LV failure. She died of multiorgan failure after 3 days of support.
A 7-year-old girl had a coarctation and ventricular septal defect repair at 15 days of life and balloon dilatation and AoV repair (leaflet replacement) at 50 and 71 days of life, respectively. A Ross-Konno procedure and mitral repair were performed at 8 months of age; she had normal systolic LV function but diastolic dysfunction with pulmonary hypertension. At 7 years of age, she developed severe intractable pulmonary hypertension and died while on the heart-lung transplant list.
Freedom from reoperation
Freedom from reoperation at 1, 5 and 7 years, respectively, was 89% (95% CI, 85-94%), 70% (95% CI, 63-78%) and 57% (95% CI, 47-66%) (Fig. 1) . Video 2: Neocommissure creation: a first commissure is split; a second, incompletely developed, commissure is also split but does not display any more support. Leaflets are then shaved. The unsupported commissure is reconstructed with a pericardial triangular patch.
The indications for reoperation were stenosis in 25 patients (8 had associated LV outflow tract obstruction), insufficiency in 27, mixed in 6, endocarditis in 3 and unreported in 4 (replacement in another centre). Indications were age related, with predominant stenotic lesions in younger patients (<10 years) compared to older patients (respectively, 54% vs 15%, P = 0.002), and predominant regurgitation in older (> _10 years) patients (54%). Characteristics of reoperated patients are presented in Supplementary Material, Table S1 . The failure mechanisms of explanted material are presented in Supplementary Material, Table S2 .
Freedom from reoperation, segregated by repair technique, is presented in Fig. 2 . Multivariate analysis identified the following predictors for reoperation (Table 2) : age at surgery, previous balloon dilatation performed before 6 months of age, the absence of any developed commissure, neocommissure creation technique, a non-tricuspid post-repair valve arrangement (Fig. 3) and cross-clamp time.
Freedom from valve replacement
Freedom from valve replacement at 1, 5 and 7 years, respectively, was 93% (95% CI, 89-97%), 77% (95% CI, 71-84%) and 68% (95% CI, 59-76%), respectively (Fig. 1) .
Multivariate analysis identified the following predictors for replacement ( Table 2) : previous balloon dilatation performed before 6 months of age (Fig. 4) , the absence of any developed commissure, a non-tricuspid post-repair valve arrangement and cross-clamp time.
Late function
At the final follow-up examination, 145 (75%) patients were surviving with their native valve.
An undisturbed valve function was present in 113 patients (peak gradient <40 mmHg, regurgitation < _mild), whereas 13 had moderate regurgitation and 7 had moderate stenosis (peak gradient of 60 mmHg).
LV function and dimensions were preserved in 157 patients. Dilatation was mild in 24 (z-score 1-2), moderate in 3 (z-score 2-2.5). LV function was mildly altered in 3, and 4 patients had pulmonary hypertension (2 diastolic dysfunction, 2 small LV or mitral valve).
DISCUSSION
Though competing in the past, AoV repair should not be opposed to other strategies (Ross procedure, balloon dilatation). This study was conducted to better define the place of AoV repair in the armamentarium to treat AoV disease in children. Ultimately, AoV repair should reduce the use of replacement procedures in the growing child.
The surgical capacity to reach a competent and non-restrictive geometry of the AoV has consistently developed over the last decade with improving imaging technologies and repair techniques. The main scopus in this field is now dominated by the question of durability, which can only be solved through followup. In this regard, our experience highlighted the prominent roles of choice of technique and growing geometry.
This retrospective study showed that repair for congenital AoV disease can be performed with a low-mortality rate and a nonprohibitive reoperation rate, sufficient to provide growth of the patient to an age when more definitive solutions are available. As applied to a growing recipient, technical strategies should be individualized to his or her age. Aiming for a tricuspid postrepair arrangement and for avoidance of early balloon dilatation improves outcomes.
General strategy
AoV repair in children is a temporary solution to postpone more definitive solutions. In this report, 145 (75%) patients were living with their native valve. In those, the treatment goal was to postpone re-repair to an age where a more definitive repair could be performed [8] or to prevent replacement. However, a substantial number of patients (21% in our cohort) will ineluctably require a valve replacement. For those, the main treatment goal is to postpone the age for this replacement. Indeed, mechanical replacement in a young child is not only associated with increasing cumulative risk of lifelong anticoagulation but also with repeated valve replacements due to child overgrowth. When an autograft replacement is preferred, there will be an increasing need for a right ventricle-pulmonary artery conduit. In addition, there is a growing body of evidence in the paediatric field that dilatation and failure of autograft occur in up to 40% of patients in the second decade [3, 4] after the Ross procedure. Techniques preventing this drawback (supported Ross) have developed [9] but can only be applied in a mature child. Performing voluntary repair(s) in the younger child would allow for aortic root growth and postponement of the Ross procedure to a time when such 'supportive' methods can be used. In the present report, of the 48 patients who eventually required aortic replacement, the median age at repair was 8.0 years, and replacement could be postponed at a median age of 12.0, which allowed in some patients the use of supportive techniques for Ross replacement [10] . Furthermore, as described later, older age may also allow consideration of further techniques for recurrent repair (such as leaflet replacement) that could have not been used in younger patients because of limited durability. Although efforts should be oriented to maintain the native valve in younger children as long as possible, preservation of LV function is also critical to this strategy. Indeed, LV failure is consistently associated with death in the Ross procedure [11, 12] . Aortic regurgitation and ventricular dysfunction lead to earlier AoV replacement [13] . For some authors, AoV repair may prolong LV exposure to pressure or volume overload and thus jeopardize future outcome for these patients [14] . In our patients, only 3 had mildly reduced ventricular function; 2 had uneventful Ross AoV replacements; and 1 is scheduled for AoV replacement. Of the 2 patients who died of pulmonary hypertension early after the Ross AoV replacement, none had ventricular systolic dysfunction. Diastolic dysfunction is poorly investigated in these patients with congenital aortic stenosis but may have contributed to this dramatic outcome. A restricting mitral valve was also present in one of those patients and is also an identified risk for post-Ross outcome in children [12, 15] .
Finally, preserving the native valve as long as possible, without affecting LV function, leaves all other options still valid without limitations (supported Ross/mechanical valve and even recurrent repair).
Staged strategy
Durability of the repair depends on material properties and geometry. In addition to the inherent failure rate of AoV repair, in children, patient growth has a major impact on repair durability. Geometry should be considered in an evolving approach. Many reported series analysed results of aortic repair techniques as a whole [5, 16] or specific techniques in a wide spectrum of ages [17] . The large number of patients in our cohort allowed us to specifically analyse outcome by combining specific techniques and age groups.
The growth potential of the AoV complex can be considered in 2 directions: vertical (from cusp nadir to Arantius nodula) and horizontal (intercommissural). Unrestrictive procedures (commissurotomy shaving or neocommissure creation) maintain growth potentials in both directions. Restrictive procedures (leaflet replacement and extension) restrain intercommissural growth. Our results show that a restrictive procedure in small children (especially under the age of 1 year) leads to a reoperation sooner rather than later. In older patients, a restrictive procedure such as leaflet replacement offers satisfying results. Surprisingly, leaflet extension (predominantly used for older children, at an age when growth potential is minimal) was associated with high-reoperation rates compared to the other restrictive leaflet-replacement procedures. Age at which the procedure occurred was similar between these groups (14.6 ± 2.5 vs 15.3 ± 3.6, P = 0.4). Extension procedures had been performed earlier, and longer follow-up may have favoured leaflet replacement results. Furthermore, to minimize the risk of coronary ostial obstruction mentioned by d'Udekem et al. [5] , the extension might have been tailored more cautiously and shorter. With increasing experience, tailoring of the leaflet replacement (longer free edge) might have benefited from the uneventful experience with the extension technique. Today, the leaflet is tailored to compensate for intercommissural growth, with a free edge length equal to twice the intercommissural distance. Another hypothesis is that calcification is stress related and occurs at the junction between tissues: in a combination of native and foreign materials, the pericardial strip might be more exposed to stress than the complete leaflet replacement where the stress is more equally distributed.
Neocommissure reconstruction, a less frequently used technique in our experience, showed promising results. Indeed, this procedure combines the benefit of the geometry of the tricuspid valve (discussed below) with the maintenance of intercommissural growth potential. In this procedure, the material is fixed only to half of the free edge of the contiguous leaflet. Therefore, such an unrestrictive procedure can be used in younger patients. Further follow-up is required to confirm these results.
Material used for aortic valve repair
To compare our results to those from other reports or to draw any sensible conclusion from the literature about material durability is deeply challenging. Indeed, the heterogeneity of material implantation reports is substantial: primarily in the recipients but also in the type (homo-or xenograft, pericardial or submucosa), treated or not, glutaraldehyde concentration, duration of exposure and rinse, pressurized or not. Finally, geometry also plays an important role. The best results have been achieved by the Polimenakos group [17] , with an 18-year freedom from replacement of 60.0% ± 7.2%. Glutaraldehyde-fixed homologous pericardium was used. Such results in a paediatric-age cohort with congenital disease must be complimented; however, they were obtained in a very selective cohort. Our report encompasses a systematic repair policy in a nonselected cohort of patients with congenital 'primary' (not secondary to other congenital heart defect) AoV disease.
In primary repairs, we always used treated autologous pericardium. Reoperation showed 2 main mechanisms of failure: restrictive motion leading to late reoperation and excessive motion leading to early reoperation. Though experience and reports in the literature have accumulated, the debate on the optimal material is still ongoing, especially given the disparity of data (children and adults mixed), the small number of paediatric patients and the new materials.
Management and risk factors
Determination of specific risk factors for outcome after AoV repair is challenging in children, because monocentric series, with limited numbers of patients, barely reach statistical significance [5, 7] . It is noteworthy that all tested preoperative factors (valve function and morphology) correlated poorly with outcome. This finding underlines the requirement for new tools (3D echocardiography) to better describe preoperative anatomy. In this respect, the number of developed commissures, identified as a risk factor in our study, might be important.
In addition, the early use of balloon dilatation significantly increased the risk for valve replacement. This observation retrospectively validates our surgically oriented policy of the last 5 years [18, 19] . The remaining indications for early balloon dilatation should be restricted to gentle ballooning for decompression of a failing LV, as an intermittent step to recovery before AoV repair.
Tricuspidization
As previously identified [20] , valve morphology influenced outcomes, with tricuspid morphology providing a protective effect against reoperation and, more importantly, against replacement. This effect may be due either to the underlying morphology, to a better geometrical configuration favouring durability or to the maintenance of the further possibility of re-repair (leaflet rereplacement instead of valve replacement). Nevertheless, in young patients, tricuspidization involved leaflet replacement in two-thirds of patients. In this age group, such a procedure has limited durability, and mitigated the superiority of tricuspidization in this age group (Fig. 3) .
Limitations
The retrospective nature of the study and the limited follow-up are the main limitations. The study covers 10 years of experience, and it is likely that intermediate results have influenced technical strategies [18] and management [19] . For didactic and analytic reasons, the techniques used were simplified to allow for classification. However, 152 patients had complex associated strategies (more than sole commissurotomy shaving), such as leaflet plication, suspension and decalcification, and 35 patients had various combinations of the 3 aforementioned techniques (leaflet replacement, extension and neocommissure creation).
CONCLUSIONS
Any operation in children (repair, Ross or mechanical replacement) is a palliation and reinterventions are frequent. AoV repair is a temporary solution to allow the patient to grow to an age when more definitive solutions are available. It is safe and effective and permits all other options without any limitations.
Surgical strategy should be individualized to the age of the patient. In young patients (<10 years), neocommissure creation is promising; 2 other techniques (commissurotomy shaving or leaflet replacement) are equally effective or ineffective. In older patients (>10 years), all techniques except leaflet extension offer 80% freedom from reoperation at 8 years of follow-up. In addition to technique, morphology also influences durability, with a tricuspid arrangement of the AoV providing a protective effect; balloon valvuloplasty before 6 months clearly mitigates the chances for long-lasting results, free of replacement.
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